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Early studies mapped the entry receptor for HTLV-1 and
HTLV-2 to the long arm of chromosome 17. However,
later observations that the titer of HTLV Env-pseudotyped
viruses was low on some mouse-human hybrid cell lines
containing human chromosome 17q led to the belief that
this gene was not involved in HTLV infection. Recent stu-
dies showing that efficient HTLV-I infection requires
three molecules (GLUT-1, NRP-1, and HSPGs), prompted
us to examine whether a gene on chromosome 17 is
related to this receptor complex.
Since NRP-1 or GLUT-1 map to other chromosomes,
we examined chromosome 17q for genes involved in the
synthesis of HSPGs. A gene at 17q21.33, XYLT2, encodes
Xylosyltransferase 2 (XT-II), one of two isoforms of an
enzyme involved in glycosaminoglycan-chain modifica-
tions on proteoglycans. Studies revealed that both the
titer of HTLV-1 pseudotyped virus and the level of bind-
ing of soluble HTLV-1 SU proteins were dramatically
lower on a cell line lacking functional xylosyltransferase
(CHOK1-745) than on the parental line (CHOK1).
Expression of transgenic XT-II in CHOK1-745 cells
increased the levels of HTLV-1 SU binding and the titer
of HTLV-1 Env pseudotypes to levels similar to those in
wild-type cells. The role of XT-II in HTLV-2 and HTLV-
3 Env-mediated entry is being investigated, as well as the
role of xylosyltransferases in the infection of T and den-
dritic cells by HTLVs. These data provide molecular evi-
dence for the previously reported association of a
chromosome 17-encoded product in HTLV-1 entry and
confirm the critical role of proteoglycans in this process.
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